Ratchaphruek Hospital Public Company Limited

SET:RPH Stock Report

Market Cap: ฿2.9b

Ratchaphruek Hospital Valuation

Is RPH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of RPH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
฿6.79
Fair Value
20.4% undervalued intrinsic discount
0
Number of Analysts


Key Valuation Metric

Which metric is best to use when looking at relative valuation for RPH?

Key metric:

The above table shows the Price to Earnings ratio for RPH. This is calculated by dividing RPH's market cap by their current earnings.
What is RPH's PE Ratio?
PE Ratio16.7x
Earnings฿175.19m
Market Cap฿2.93b

Price to Earnings Ratio vs Peers

How does RPH's PE Ratio compare to its peers?

The above table shows the PE ratio for RPH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.5x
LPH Ladprao General Hospital
44.2xn/a฿3.1b
TRP Aesthetic Connect
17.2x22.1%฿2.6b
AHC Aikchol Hospital
13.6xn/a฿2.3b
NKT Nakornthon Hospital
11.1x-8.0%฿2.6b
RPH Ratchaphruek Hospital
16.7xn/a฿2.9b


Price to Earnings Ratio vs Industry

How does RPH's PE Ratio compare vs other companies in the TH Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
RPH 16.7xIndustry Avg. 19.1xNo. of Companies10PE01020304050+
0 CompaniesEstimated GrowthMarket Cap
No more companies


Price to Earnings Ratio vs Fair Ratio

What is RPH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RPH PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.7x
Fair PE Ration/a


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 04:43
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ratchaphruek Hospital Public Company Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Narumon EkasamutBualuang Securities PCL
null nullDBS Bank Ltd
null nullDBS Vickers Research